Risk for Unplanned Hospital Readmission of Patients With Cancer: Results of a Retrospective Medical Record Review

Abstract

The factors identified provide a basis for assessment, planning, interventions, and follow-up of patients to help reduce the risk of readmission and, thus, poor outcomes.

Unplanned oncology admissions within 14 days of non-surgical discharge: a retrospective study

“…Breast, colorectal and upper UGI cancers are well reported in international studies as malignancies most commonly associated with unplanned oncology admissions [1,11,15,23,25,26]. The UPA data for these malignancies are well represented in this study with the variances being a high prevalence of gynaecological cancers and a low prevalence of lung cancers requiring UPA from those reported internationally [1,11,15,23,[25][26][27][28].…”

“…The UPA data for these malignancies are well represented in this study with the variances being a high prevalence of gynaecological cancers and a low prevalence of lung cancers requiring UPA from those reported internationally [1,11,15,23,[25][26][27][28]. The study hospital has two oncologists who specialise in the management of gynaecological malignancies, and no oncologist that specialises in the management of lung malignancies, this is a likely cause of this difference.…”

“…However, this hospital specialises in UGI management, offering treatment that is not readily available elsewhere in the state. Given that UGI malignancies have been associated with unplanned presentation and admission [1,3,11,15,23,25] and that the study hospital treats a disproportionate number of UGI malignancies, it would be reasonable to assess risk and implement support for this group of patients at diagnosis.…”

“…Without appropriate palliative care referrals, patients with metastatic disease commonly seek symptomatic relief through emergency presentation and inpatient hospitalisation [20,22]. By incorporating appropriate community support, there is the potential to reduce presentations and hospitalisations by cancer patients for what is often end of life care [21][22][23]. The number of terminal admissions that occurred within the short study period and the low levels of palliative care intervention that were recorded represent opportunities for improvement in integrated care between oncology and palliative.…”

Transition of Symptoms and Quality of Life in Cancer Patients on Chemotherapy

“…또한 이러한 증상 경험은 예기치 않은 재입원의 주요 원인 및 생존율을 예측 하는 중요한 인자이나, 많은 환자들은 치료의 부작용에 대처하 는데 어려움을 호소하고 있다 (Fox & Lyon, 2006). 따라서, 적 절한 투약 및 자가 간호 방법, 유용한 자원 등에 대한 정보를 제 공하는 것이 중요하며 (Weaver et al, 2006), 이를 위해 종단적 연구방법을 적용하여 항암치료의 합병증 등으로 인한 환자들의 건강상태의 변화양상을 보다 포괄적으로 제시할 필요성이 요구 된다 (Chung et al, 2005).…”